Aslan Pharmaceuticals: Kenneth Kobayashi, CMO
Aslan Pharmaceuticals has appointed Kenneth Kobayashi chief medical officer. Kobayashi will be based in the California office of the Singapore-based company.
Kobayashi brings to the company more than 25 years of experience in drug development, clinical practice and regulatory affairs, with a specialty in dermatology. Most recently he served as senior medical director at Dermira, a subsidiary of Eli Lilly, where he was responsible for the development of lebrikizumab, a monoclonal antibody for atopic dermatitis.